1. Taillefer R, Robidoux A, Lambert R, Turpin S, Laperriere J. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 1995;36:1758–1765.
2. Maublant JC, Zhang Z, Rapp M, Ollier M, Michelot J, Veyre A. In vitro update of technetium-99m-teboroxime in carcinoma cell lines and normal cells: comparison with technetium-99m-sestamibi and thallium-201. J Nucl Med 1993;34:1949–1952.
3. Melloul M, Paz A, Ohana G, Laver O, Michalevich D, Koren R, et al. Double-phase 99m Tc-sestamibi scintimammography and trans-scan in diagnosing breast cancer. J Nucl Med 1999;40:376–380.
4. Maini L, de Notaristefani F, Tofani A, Lacopi F, Scjuto R, Semprebene A, et al. 99m Tc-MIBI scintimammography using a dedicated nuclear mammography. J Nucl Med 1999;40:46–51.
5. Thrall J, Ziessman H, editors. The requisites nuclear medicine. St. Louis: Mosby; 2001. p. 36–39.